
    
      Primary aim:

      To determine the feasibility of the use of LLLT for HNC survivors with lymphedema,
      specifically to 1) obtain recruitment estimates and determine barriers to recruitment; 2)
      identify barriers to implementation; 3) assess safety; and 4) evaluate patient satisfaction.
    
  